Table 1. General characteristics of the study population grouped by urinary albumin excretion.
| No Malb | Malb | P | |
| Number of samples | 1150 | 81 | |
| Sex (M/F) | 582 (93.4)/568 (93.4) | 41 (6.6)/40 (6.6) | 1 |
| Age (years) | 53±19 | 67±18 | 0.052 |
| BMI (kg/m2) | 26±6 | 28±5 | 0.026 |
| SBP (mm Hg) | 129±21 | 153±29 | 7.3 E-10 |
| DBP (mm Hg) | 79±12 | 83±13 | 0.002 |
| Glycemia (mg/dl) | 92±20 | 104±29 | 9.5 E-7 |
| Creatinine (g/24 h) | 112±56 | 118±64 | 0.315 |
| Total Cholesterol (mg/dl) | 201±38 | 202±42 | 0.846 |
| LDL (mg/dl) | 114±35 | 114±34 | 0.895 |
| HDL (mg/dl) | 52±14 | 47±14 | 0.040 |
| LogTG (mg/dl) | 2.18±0.23 | 2.26±0.20 | 0.002 |
| Diabetes mellitus 2 | 77 (6.7) | 22 (27.2) | <0.0001 |
| Hypertension | 450 (39.1) | 64 (79.0) | <0.0001 |
| Metabolic syndrome | 237 (20.6) | 47 (58) | <0.0001 |
| Obesity | 258 (22.4) | 31 (38.3) | <0.0001 |
| HTN treatment | 203 (17.7) | 36 (44.4) | <0.0001 |
| DM treatment | 42 (3.7) | 12 (14.8) | <0.0001 |
| HCT-TG treatment | 72 (6.3) | 11 (13.6) | 0.019 |
() percentage.